Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Caribou Biosciences (CRBU) Short-term Investments (2021 - 2025)

Historic Short-term Investments for Caribou Biosciences (CRBU) over the last 5 years, with Q3 2025 value amounting to $136.1 million.

  • Caribou Biosciences' Short-term Investments fell 3062.72% to $136.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $136.1 million, marking a year-over-year decrease of 3062.72%. This contributed to the annual value of $193.2 million for FY2024, which is 3040.39% down from last year.
  • According to the latest figures from Q3 2025, Caribou Biosciences' Short-term Investments is $136.1 million, which was down 3062.72% from $158.7 million recorded in Q2 2025.
  • In the past 5 years, Caribou Biosciences' Short-term Investments registered a high of $277.7 million during Q4 2023, and its lowest value of $135.4 million during Q4 2021.
  • In the last 5 years, Caribou Biosciences' Short-term Investments had a median value of $194.7 million in 2024 and averaged $198.9 million.
  • Per our database at Business Quant, Caribou Biosciences' Short-term Investments soared by 4666.05% in 2023 and then plummeted by 3062.72% in 2025.
  • Quarter analysis of 5 years shows Caribou Biosciences' Short-term Investments stood at $135.4 million in 2021, then soared by 39.81% to $189.3 million in 2022, then skyrocketed by 46.66% to $277.7 million in 2023, then plummeted by 30.4% to $193.2 million in 2024, then decreased by 29.56% to $136.1 million in 2025.
  • Its Short-term Investments was $136.1 million in Q3 2025, compared to $158.7 million in Q2 2025 and $179.0 million in Q1 2025.